Takeshi Mori

8.7k total citations
369 papers, 6.4k citations indexed

About

Takeshi Mori is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Takeshi Mori has authored 369 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Molecular Biology, 47 papers in Infectious Diseases and 44 papers in Epidemiology. Recurrent topics in Takeshi Mori's work include RNA Interference and Gene Delivery (50 papers), Advanced biosensing and bioanalysis techniques (48 papers) and Antifungal resistance and susceptibility (33 papers). Takeshi Mori is often cited by papers focused on RNA Interference and Gene Delivery (50 papers), Advanced biosensing and bioanalysis techniques (48 papers) and Antifungal resistance and susceptibility (33 papers). Takeshi Mori collaborates with scholars based in Japan, Taiwan and United States. Takeshi Mori's co-authors include Yoshiki Katayama, Takuro Niidome, Yasuro Niidome, Jeong‐Hun Kang, Yasuyuki Akiyama, Takahito Kawano, Mizuo Maeda, Akihiro Kishimura, Keiji Minagawa and Masami Tanaka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and SHILAP Revista de lepidopterología.

In The Last Decade

Takeshi Mori

348 papers receiving 6.2k citations

Peers

Countries citing papers authored by Takeshi Mori

Since Specialization

Citations

This map shows the geographic impact of Takeshi Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Mori more than expected).

Fields of papers citing papers by Takeshi Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Mori. The network helps show where Takeshi Mori may publish in the future.

Co-authorship network of co-authors of Takeshi Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Mori. A scholar is included among the top collaborators of Takeshi Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Mori. Takeshi Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thermosensitive Nanostructured Coacervates Developed by Mixing ABA‐ and AB‐Block Copolymers and Their Unique Sustained Release of Nano‐Micelles in a Regulated Manner 2025 ·Small ·(unknown), (unknown), Y. Hamada, (unknown), Hiroshi Yoshikawa, Yuji Higaki, Atsushi Takahara, Takeshi Mori, Yoshiki Katayama, Akihiro Kishimura	0
2	Oral Administration of PLGA Nanoparticles to Deliver Antisense Oligonucleotides to Inflammatory Lesions in the Gastrointestinal Tract 2024 ·Biological and Pharmaceutical Bulletin ·(unknown), Yiwei Liu, Jinting Li, (unknown), (unknown), (unknown), Teruki Nii, Takeshi Mori, Yoshiki Katayama	5
3	Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children’s Cancer Group Multicentre Trial, JPLSG B-NHL-20) 2024 ·BMJ Open ·Masahiro Sekimizu, Reiji Fukano, Yuhki Koga, Tetsuo Mitsui, Naoto Fujita, Takeshi Mori, (unknown), Makito Tanaka, Kentaro Ohki, (unknown), Atsuko Nakazawa, Tetsuya Mori, Ryōji Kobayashi, Hiroya Hashimoto, Akiko Saito, (unknown)	2
4	Dynamic frustrated charge hotspots created by charge density modulation sequester globular proteins into complex coacervates 2023 ·Chemical Science ·(unknown), Teruki Nii, Takeshi Mori, Yoshiki Katayama, Akihiro Kishimura	11
5	One-pot preparation of mannan-coated antigen nanoparticles using human serum albumin as a matrix for tolerance induction 2023 ·Journal of Colloid and Interface Science ·Shunyi Li, (unknown), Satoru Nagatoishi, (unknown), Kouhei Tsumoto, Yoshiki Katayama, Takeshi Mori	2
6	Minimal residual disease detected by droplet digital PCR in peripheral blood stem cell grafts has a prognostic impact on high-risk neuroblastoma patients 2022 ·Heliyon ·(unknown), Toshiaki Ishida, (unknown), (unknown), (unknown), (unknown), Akihiro Nishimura, (unknown), Akihiro Tamura, Nobuyuki Yamamoto, (unknown), (unknown), Takeshi Mori, Daiichiro Hasegawa, Yoshiyuki Kosaka, Kandai Nozu, Noriyuki Nishimura	2
7	Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against Staphylococcus aureus, Escherichia coli, and Candida albicans 2021 ·International Journal of Molecular Sciences ·Takeshi Mori, Miyako Yoshida, Mai Hazekawa, Daisuke Ishibashi, (unknown), Toshihiro Nagao, Rie Kakehashi, (unknown), (unknown), Minoru Ozeki, Ikuo Kawasaki, Taku Yamashita, Jun‐ichi Nishikawa, Takahiro Uchida	9
8	Synthesis and biological evaluation of a monocyclic Fc-binding antibody-recruiting molecule for cancer immunotherapy 2021 ·RSC Medicinal Chemistry ·Koichi Sasaki, (unknown), (unknown), (unknown), Atsuhiko Taniguchi, Akihiro Kishimura, Yoshio Hayashi, Takeshi Mori, Yoshiki Katayama	6
9	Targeted Delivery of Miconazole Employing LL37 Fragment Mutant Peptide CKR12-Poly (Lactic-Co-Glycolic) Acid Polymeric Micelles 2021 ·International Journal of Molecular Sciences ·Takeshi Mori, Miyako Yoshida, Mai Hazekawa, Daisuke Ishibashi, (unknown), Rie Kakehashi, (unknown), Toshihiro Nagao, (unknown), (unknown), (unknown), Takahiro Uchida	4
10	Modification of nitric oxide donors onto a monoclonal antibody boosts accumulation in solid tumors 2020 ·International Journal of Pharmaceutics ·Takuma Yoshikawa, (unknown), (unknown), Koichi Sasaki, (unknown), Akihiro Kishimura, Takeshi Mori, Yoshiki Katayama	2
11	Induction of ADCC by a folic acid–mAb conjugate prepared by tryptophan-selective reaction toward folate-receptor-positive cancer cells 2020 ·RSC Advances ·(unknown), Katsuya Maruyama, Koichi Sasaki, (unknown), Akihiro Kishimura, Motomu Kanai, Takeshi Mori, Kounosuke Oisaki, Yoshiki Katayama	9
12	Fc-binding antibody-recruiting molecules exploit endogenous antibodies for anti-tumor immune responses 2020 ·Chemical Science ·Koichi Sasaki, (unknown), (unknown), (unknown), Akihiro Kishimura, Takeshi Mori, Yoshiki Katayama	17
13	Fc‐Binding Antibody‐Recruiting Molecules Targeting Prostate‐Specific Membrane Antigen: Defucosylation of Antibody for Efficacy Improvement** 2020 ·ChemBioChem ·Koichi Sasaki, (unknown), Takuma Yoshikawa, (unknown), Yui Harada, Yoshikazu Yonemitsu, (unknown), Akihiro Kishimura, Takeshi Mori, Yoshiki Katayama	9
14	A peptide inhibitor of antibody-dependent cell-mediated cytotoxicity against EGFR/folate receptor-α double positive cells 2018 ·MedChemComm ·Koichi Sasaki, (unknown), Daisuke Asai, Daiki Funamoto, Kazuki Sato, Yoko Yamaguchi, Yuji Mishima, Tadafumi Iino, Shigeo Takaishi, Jun Nagano, Akihiro Kishimura, Takeshi Mori, Yoshiki Katayama	6
15	Effect of thymectomy for thymic atrophy in myasthenia gravis: A retrospective study on 93 patients 2017 ·Journal of Neuroimmunology ·Keiichi Nakahara, Shunya Nakane, Makoto Nakajima, Satoshi Yamashita, Takeshi Mori, Yukio Ando	9
16	Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus 2012 ·SHILAP Revista de lepidopterología ·Takeshi Mori, Takumi Umemura, Mao Hagihara, Hiroshige Mikamo	0
17	2010 ·Japanese Journal of Infection Prevention and Control ·Takumi Umemura, Takahiro Mochizuki, Yuichi Muraki, (unknown), (unknown), Norio Ohmagari, Yuka Yamagishi, Hiroshige Mikamo, Takeshi Mori	6
18	In vivo siRNA delivery with dendritic poly( l -lysine) for the treatment of hypercholesterolemia 2009 ·Molecular BioSystems ·Kazuto Watanabe, Mariko Harada‐Shiba, Akira Suzuki, (unknown), (unknown), (unknown), Takeshi Mori, Yoshiki Katayama, Takuro Niidome	66
19	Inflammatory cell‐specific transgene expression system responding to Iκ‐B kinase beta activation 2009 ·The Journal of Gene Medicine ·Daisuke Asai, Akira Tsuchiya, Jeong‐Hun Kang, Kenji Kawamura, Jun Oishi, Takeshi Mori, Takuro Niidome, Yôko Shôji, Hideki Nakashima, Yoshiki Katayama	16
20	A CYTOCHROME FROM HALOTOLERANT BACTERIA 1953 ·The Journal of Biochemistry ·Fujio Egami, (unknown), Ryo Sato, Takeshi Mori	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact